When it comes to your skin, trends come and go. Proven technology doesn’t.
At Dermology, our philosophy has always been simple: invest in treatments backed by science, recognised by industry leaders, and trusted by medical professionals around the world. That’s why we’re incredibly proud to offer treatments like MOXI® and SkinPen®, both of which have recently received prestigious recognition in the ELLE 2026 Tools & Treatments Awards.
MOXI was named Best Lunchtime Laser, while SkinPen was awarded Best Microneedling Treatment, further reinforcing what we’ve believed for years—these technologies deliver exceptional results with proven safety and clinical effectiveness.
Dermology’s Commitment to Award-Winning Aesthetic Technology
The aesthetic industry evolves rapidly. Every year, hundreds of new devices, treatments and technologies enter the market, each promising revolutionary results.
Rather than chasing trends, Dermology carefully selects technologies based on:
- Clinical evidence
- Long-term patient outcomes
- Global recognition
- Safety across multiple skin types
- Consistent innovation
- Scientific research and published data
Our investment strategy ensures that every treatment available at Dermology has earned its place through performance—not marketing.
This commitment is one of the reasons Dermology continues to be recognised as one of South Africa’s leading aesthetic laser and skin clinics.
MOXI Named ELLE’s Best Lunchtime Laser
The latest international recognition comes from one of the beauty industry’s most respected publications.
In the ELLE 2026 Tools & Treatments Awards, MOXI was awarded Best Lunchtime Laser, recognising its ability to deliver noticeable skin rejuvenation with minimal downtime. ELLE described MOXI as a gentle fractional laser that fits easily into busy lifestyles while improving skin tone, brightness and overall skin quality.
What is MOXI?
MOXI is Sciton’s non-ablative fractional laser designed to improve:
- Early signs of ageing
- Uneven skin tone
- Sun damage
- Pigmentation
- Fine lines
- Skin texture
- Enlarged pores
Unlike aggressive resurfacing lasers, MOXI stimulates skin renewal beneath the surface while allowing patients to return to normal daily activities relatively quickly.
This has made it one of the world’s most popular “prejuvenation” treatments—a proactive approach to maintaining healthy skin before significant ageing develops.
At Dermology, MOXI is frequently combined with BBL HERO™ as part of our exclusive BOXI™ protocol, allowing us to target pigmentation, redness, collagen stimulation and overall skin quality within a customised treatment plan.
SkinPen Named Best Microneedling Treatment
ELLE also recognised SkinPen as the Best Microneedling Treatment of 2026. The publication highlighted SkinPen’s status as the first FDA-cleared microneedling device and praised its ability to stimulate collagen production while improving skin texture and overall skin quality.
Why SkinPen Continues to Set the Standard
Microneedling has become one of the most requested skin treatments worldwide.
However, not all microneedling devices are created equal.
SkinPen is considered the gold standard because it offers:
- Precision engineering
- Controlled needle depth
- Excellent safety profile
- Predictable collagen stimulation
- Evidence-based treatment protocols
At Dermology, SkinPen is commonly used to improve:
- Acne scars
- Surgical scars
- Fine lines
- Wrinkles
- Skin texture
- Large pores
- Overall skin rejuvenation
Every treatment is tailored according to the individual’s skin condition rather than following a one-size-fits-all approach.
Technology Is Only as Good as the Team Behind It
Award-winning technology is important.
Award-winning expertise matters even more.
The world’s best laser in inexperienced hands cannot consistently produce exceptional outcomes.
At Dermology, every treatment begins with an in-depth consultation, allowing our clinicians to assess:
- Skin health
- Skin concerns
- Medical history
- Lifestyle
- Previous treatments
- Long-term skin goals
From there, we build a customised treatment protocol that may combine multiple technologies and medical-grade skincare to achieve optimal results.
This personalised approach is what sets Dermology apart.
Global Recognition Reflects a Bigger Commitment
MOXI and SkinPen joining the list of internationally recognised treatments reinforces something we have believed from the beginning:
Patients deserve access to technology that has been independently recognised for delivering outstanding clinical outcomes.
Dermology continues to invest in globally awarded technologies because innovation never stands still.
Whether it’s Sciton laser platforms, advanced microneedling, medical-grade skincare or combination treatment protocols, our goal is always the same:
To provide South Africans with access to some of the world’s most advanced aesthetic treatments—without having to travel overseas.
Why Choosing an Award-Winning Clinic Matters
When choosing an aesthetic clinic, many patients naturally ask:
“What treatment should I have?”
An equally important question is:
“Who is performing it?”
Technology, training, clinical experience and personalised treatment planning all work together to produce outstanding results.
At Dermology, we don’t simply purchase new devices—we invest in ongoing education, international training, scientific collaboration and continuous protocol refinement to ensure our patients receive treatments aligned with the latest global standards.
Experience Globally Recognised Treatments at Dermology
Whether you’re looking to prevent early signs of ageing, improve pigmentation, reduce acne scars or simply maintain healthy, radiant skin, Dermology offers internationally recognised treatment options tailored specifically to you.
From the award-winning MOXI laser to SkinPen microneedling, our commitment remains unchanged:
To bring the world’s best technology, backed by science and recognised globally, directly to South African patients.
Why Dermology Chooses Award-Winning Technology
Not every new aesthetic device that enters the market becomes a lasting success.
At Dermology, we don’t invest in technology simply because it’s new—we invest because it has proven itself through scientific research, clinical outcomes, and international recognition. Before introducing any treatment into our clinics, we evaluate the evidence, the safety profile, the quality of the technology, and most importantly, the results it consistently delivers for patients.
Here’s what guides every investment we make:
| Dermology’s Standard | Why It Matters to Our Patients |
|---|---|
| Globally recognised technology | Independent awards and international recognition demonstrate consistent performance beyond marketing claims. |
| Evidence-based science | Treatments supported by published clinical studies provide greater confidence in safety and predictable outcomes. |
| Medical-grade innovation | We partner with internationally respected manufacturers known for ongoing research and development. |
| Continuous education | Our providers receive ongoing local and international training to remain at the forefront of laser and skin technology. |
| Customised treatment protocols | Every treatment is tailored to the skin in front of us—not copied from a standard settings sheet. |
| Long-term skin health | Our focus isn’t quick fixes. We create personalised treatment plans designed to improve skin health for years to come. |
How Our Award-Winning Treatments Compare
| Treatment | International Recognition | Best For | Downtime |
| MOXI® | ELLE Best Lunchtime Laser 2026 | Early ageing, pigmentation, sun damage, skin texture, preventative skin rejuvenation | Minimal |
| SkinPen® | ELLE Best Microneedling Treatment 2026 | Acne scars, fine lines, enlarged pores, collagen stimulation and skin texture | Low |
| BBL HERO™ | Industry-leading broadband light technology used by leading aesthetic practices worldwide | Pigmentation, redness, acne, rosacea, vascular lesions and visible signs of ageing | Minimal |
| BOXI™ (Dermology Exclusive) | Dermology’s signature protocol combining MOXI and BBL HERO | Comprehensive skin rejuvenation by treating pigmentation, redness, collagen production and overall skin quality in a single customised treatment journey | Minimal to low |
Why This Matters
Awards alone don’t produce beautiful skin.
Technology alone doesn’t either.
Exceptional results come from combining world-class technology with clinical expertise, careful patient assessment and personalised treatment planning.
That’s why Dermology continues to invest in globally recognised treatments—not because they’re fashionable, but because they consistently deliver results backed by science.
When international experts recognise technologies like MOXI and SkinPen as leaders in their categories, it reinforces our commitment to bringing South Africans access to some of the world’s most trusted aesthetic treatments.
Frequently Asked Questions
Is MOXI suitable for all skin types?
Yes. MOXI is considered safe for many skin types when performed by trained providers using appropriate treatment parameters and personalised protocols.
What makes MOXI different from other lasers?
MOXI is a non-ablative fractional laser that rejuvenates the skin with minimal downtime, making it an excellent option for busy lifestyles and year-round skin maintenance.
Why is SkinPen considered the gold standard in microneedling?
SkinPen was the first FDA-cleared microneedling device and has extensive clinical research supporting its safety, precision and collagen-stimulating benefits.
Can MOXI and SkinPen be combined?
Yes. Depending on your skin concerns, your Dermology practitioner may recommend combining treatments within a customised treatment plan to maximise results while maintaining skin health.
